A Phase 1/2 Study of CT120 in Patient With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Clinical trial NCT05091541 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05091541
- Sponsor
- Nanjing IASO Biotechnology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-20
- Primary completion
- 2024-10-20
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.